Insulet

Yahoo Finance • yesterday

What Analysts Think Is Shifting The Story For Insulet (PODD) And Its Edge Now

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Insulet’s fair value estimate has been nudged from US$373.84 to US$369.64, and the discount rate used in the analysis has b... Full story

Yahoo Finance • 5 days ago

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates, compatible with Abbott and Dexcom continuous glucose sensors Inaugural launch of Omnipod Discover... Full story

Yahoo Finance • last month

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of the iDose TR launch and a robust product pipeline. However, stiff competition is a concern. Shares of this Zacks Rank #3 (Hold) company have gained 12.5% so far this year c... Full story

Yahoo Finance • 2 months ago

Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026

Insulet Corporation (NASDAQ:PODD) is one of the best growth stocks to buy in 2026. On December 18, Truist lowered the firm’s price target on Insulet to $390 from $412 with a Buy rating on the shares. This sentiment was posted as part of th... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: UnitedHealth, Eli Lilly, and Bristol Myers in focus

Wall Street's major averages closed in the green on Friday, as traders assessed fresh inflation data in hopes of gauging the Federal Reserve's monetary policy. The benchmark S&P 500 closed +0.2%, while the Nasdaq Composite ended +0.3%, an... Full story

Yahoo Finance • 2 months ago

3 Quality Compounders to Keep an Eye On

Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more profits. Rinse and repeat. Companies with these characteristics are our definition... Full story

Yahoo Finance • 3 months ago

How the Narrative Around Insulet Is Evolving After Investor Day and New Analyst Targets

Insulet’s stock price target has recently been raised, with the fair value estimate increasing from $366 to $378 following the company's Investor Day and updated outlook. This change reflects strengthened confidence in Insulet’s multi-year... Full story

Yahoo Finance • 3 months ago

Insulet upgraded at UBS ahead of analyst day on growth prospects

[Wall Street New York stock exchange stock market] alexsl Shares of Insulet Corporation (PODD [https://seekingalpha.com/symbol/PODD]) traded higher on Wednesday after UBS upgraded the insulin pump maker to Buy from Neutral just ahead of i... Full story

Yahoo Finance • 3 months ago

The Wild Ride That Sent IBD Stock Of The Day Insulet Into An Early Breakout

Insulet is Thursday's IBD Stock Of The Day. After a wild post-earnings reaction, Insulet stock is in a consolidation with an early entry. Continue Reading View Comments... Full story

Yahoo Finance • 3 months ago

Insulet Stock Goes On A Wild Journey Following Its Beat-And-Raise Quarter

Insulet stock yo-yoed Thursday despite broadly beating sales forecasts for its body-worn insulin pump, Omnipod. Continue Reading View Comments... Full story

Yahoo Finance • 3 months ago

Insulet Q3 Profit Rises

(RTTNews) - Insulet Corporation (PODD) Thursday reported third-quarter net income of $87.6 million or $1.24 per share, compared with $77.5 million, or $1.08 per share in the prior year. Adjusted net income was $87.8 million or $1.24 per s... Full story

Yahoo Finance • 3 months ago

RBC Capital Lifts Insulet (PODD) PT to $365 on Strong Momentum, Q3 Guidance Optimism

Insulet Corporation (NASDAQ:PODD) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 10, RBC Capital raised the price target on Insulet to $365 from $350 and kept an Outperform rating on the shares as part of a... Full story

Yahoo Finance • 3 months ago

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

Insulet launches campaign inspired by the International Diabetes Federation’s focus on diabetes, well-being, and the workplace "The Day Diabetes Showed Up to Work" campaign recognizes the unique needs of a person with diabetes in their pro... Full story

Yahoo Finance • 3 months ago

United States Insulin Pump Market Outlook and Company Analysis Report 2025-2033 Featuring Medtronic, Insulet, Tandem Diabetes Care, Roche, Ypsomed, Microtech Medical

Company Logo The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a CAGR of 5.84% from 2025-2033. This growth is driven by the rising diabetes prevalence, technological... Full story

Yahoo Finance • 4 months ago

Notable healthcare headlines for the week: Novo Nordisk, Bristol Myers Squibb and J&J in focus

Tom Werner Wall Street's major averages plummeted on Friday after U.S. President Donald Trump threatened higher tariffs to China, saying it had "become very hostile" sending letters to other countries wanting to "impose export controls."... Full story

Yahoo Finance • 4 months ago

Notable healthcare headlines for the week: Pfizer, Novo Nordisk and JNJ in focus

Wall Street’s broader market averages closed mixed on Friday as market participants digested the U.S. government shutdown for the third day. For the week, the Dow, S&P 500, and Nasdaq Composite advanced by 1.1%, 1.08%, and 1.32%, respecti... Full story

Yahoo Finance • 5 months ago

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

From Pod to Pantone: Omnipod Mango becomes an iconic color First of its kind collaboration celebrates individualism and a personal journey toward empowerment for people living with diabetes ACTON, Mass., September 18, 2025--(BUSINESS WIRE... Full story

Yahoo Finance • 5 months ago

Insulet taps new CFO; expects to top Q3 revenue growth outlook

Insulet (NASDAQ:PODD [https://seekingalpha.com/symbol/PODD]) has named seasoned financial executive Flavia Pease as its new CFO, effective September 30, 2025. Pease will succeed Ana Maria Chadwick, who will stay on as senior advisor to he... Full story

Yahoo Finance • 5 months ago

Which S&P500 stocks are moving on Wednesday?

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE C... Full story

Yahoo Finance • 5 months ago

These S&P500 stocks are gapping in today's session

Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT ORCL [https://www.... Full story